News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
January, 2025
January 2025
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
2728293031  
Daneng Li: SKYSCRAPER-14 a Phase III study on advanced hepatocellular carcinoma
Photo from Daneng Li/X
Jun 16, 2024, 20:00

Daneng Li: SKYSCRAPER-14 a Phase III study on advanced hepatocellular carcinoma

Daneng Li, GI Medical Oncologist at City of Hope, shared on X/Twitter:

“Out now, the Methods Full article: IMbrave152/SKYSCRAPER-14: a Phase III study of atezolizumab, bevacizumab and tiragolumab in advanced hepatocellular carcinoma. 1st global study with Atezo/bev as comparator. Hopeful for patients with hepatocellular carcinoma.”

Source: Daneng Li/X

 

advanced hepatocellular carcinoma atezolizumab Bevacizumab City of Hope City of Hope Department of Medical Oncology Daneng Li hepatocellular carcinoma SKYSCRAPER-14 Tiragolumab
Special Coverage
Blog
Jan 15, 2025, 11:08
Why Dana-Farber Direct Connect? - Dana-Farber Cancer Institute
Blog
Jan 15, 2025, 10:56
Sachin H. Jain: The path forward for the US Health Insurance Industry begins with saying “We Are Sorry”
Blog
Jan 15, 2025, 08:23
Pashtoon Kasi: Different kind of liquid biopsies in guiding care of patients with cancer
Blog
Jan 15, 2025, 08:14
Chokri Ben Lamine: Immune Targets in Hematologic Malignancies
Blog
Jan 15, 2025, 08:06
Shushan Hovsepyan: 20 million participants at the first-ever 2025 CACA-OncoDaily-SPCC Cancer Summit
Opinion
Jan 15, 2025, 07:58
The Power of Equity: Funding Research to Close Gaps in Colorectal Cancer Outcomes
Blog
Jan 15, 2025, 07:53
Moses Echodu: Recounting 2024 and Looking at 2025 - Growth and Acceleration
Blog
Jan 15, 2025, 07:49
Breaking Ground in Genomics: India Launches "Genome India" Database - Canary Oncoceutics
Science
Jan 15, 2025, 07:40
Anirban Maitra: The impact of KRAS allelic status on outcomes in Pancreatic Cancer
Science
Jan 15, 2025, 07:31
Melvin LK Chua: Chromatin-related adaptation for acquired Radioresistance in Head and Neck Cancer
Blog
Jan 15, 2025, 07:27
Akhil Santhosh: I am among the recipients of the ASCO IDEA award 2025
Societies
Jan 15, 2025, 07:22
Benjamin Ebert: Excited to launch the Center for RAS Therapeutics